Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
Clinical trial NCT00157092 · COMPLETED
Trial details
- NCT number
- NCT00157092
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2004-10-14
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.